Exploring the Efficacy, Safety and Cost-effectiveness Analysis of Cadonilimab in the Treatment of Cervical Cancer

NCT06140589 · clinicaltrials.gov ↗

RECRUITING

Status

200

Enrollment

OTHER_GOV

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: Cadonilimab

Sponsor

Fujian Cancer Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]